title: Thrombotic microangiopathy complicating pegylated interferon treatment of hepatitis C infection.
authors.affiliation: Department of Haematology, London W2 1NY, United Kingdom.
authors.forename: Deena
authors.initials: D
authors.lastname: Iskander
authors.forename: Melissa
authors.initials: M
authors.lastname: Wickremasinghe
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Bain
mesh_terms: D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006526:Hepatitis C / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D057049:Thrombotic Microangiopathies / Q000139:chemically induced*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a